chartexchange

STTK
Shattuck Labs, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
4.47USD-2.614%(-0.12)2,075,320
After-hoursNov 18, 2026 4:27:30 PM EST
4.47USD0.000%(0.00)
Loading…
Loading…
455.24M
Healthcare
Biotechnology
HQ
Austin, TX, USA
Previous Close
$4.59
Beta
1.28
52-Week High
$8.33 2026-04-20
52-Week Low
$1.88 2025-11-20
SMA 50
$5.68
SMA 200
$6.08
Avg. Vol 10D
1.19M
Avg. Vol 30D
1.08M
Avg. Vol 90D
1.17M
Relative Vol
1.92
101.84M
87.49M
10,745,702
0.4400%
1,424
Mar 11, 2027 (112d)
STTK Profile

shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. compounds derived from shattuck's proprietary agonist redirected checkpoint, arc®, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. the company's lead wholly owned program, sl-172154 (sirpα-fc-cd40l), which is designed to block the cd47 immune checkpoint and simultaneously agonize the cd40 pathway, is being evaluated in a phase 1 trial. a second compound, sl-279252 (pd1-fc-ox40l), is being evaluated in a phase 1 trial in collaboration with takeda pharmaceuticals. additionally, the company is advancing a proprietary gamma delta t cell engager, gadlen™, platform, which is designed to bridge gamma delta t cells to tumor antigens for the treatment of patients with cancer. shattuck has offices in both austin, tex

STTK Performance
PeriodPriceDateChangeBeta
1W4.812026-11-12-7.07%-2.012
1M5.372026-10-19-16.76%2.165
3M7.662026-08-19-41.65%1.781
6M5.792026-05-19-22.80%1.466
1Y1.962025-11-19+128.06%1.281
2Y1.142024-11-19+292.11%—
5Y9.402021-11-19-52.45%1.394
STTK Stock Summary

Shattuck Labs, Inc. Common Stock (NASDAQ:STTK) stock price today is $4.47, and today's volume is 2,075,320. STTK is down 2.614% today. The 30 day average volume is 1.08M. STTK market cap is $455.24M with 101.84M shares outstanding.